XETRA - Delayed Quote EUR

SCHOTT Pharma AG & Co. KGaA (1SXP.DE)

Compare
24.38
-0.64
(-2.56%)
At close: 5:35:25 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
957,091.00
957,091.00
898,602.00
821,144.00
648,668.00
Cost of Revenue
634,481.00
634,481.00
582,113.00
524,717.00
422,499.00
Gross Profit
322,610.00
322,610.00
316,489.00
296,427.00
226,169.00
Operating Expense
132,654.00
132,654.00
145,566.00
127,090.00
110,920.00
Operating Income
189,956.00
189,956.00
170,923.00
169,337.00
115,249.00
Net Non Operating Interest Income Expense
-7,940.00
-7,940.00
-2,303.00
-6,847.00
-4,632.00
Pretax Income
183,971.00
183,971.00
185,802.00
158,288.00
123,284.00
Tax Provision
33,626.00
33,626.00
33,868.00
32,440.00
22,117.00
Net Income Common Stockholders
149,685.00
149,685.00
151,842.00
125,379.00
100,753.00
Diluted NI Available to Com Stockholders
149,685.00
149,685.00
151,842.00
125,379.00
100,753.00
Basic EPS
0.99
0.99
1.01
0.83
0.67
Diluted EPS
0.99
0.99
1.01
0.83
0.67
Basic Average Shares
150,615.00
150,615.00
150,615.00
150,614.62
150,614.62
Diluted Average Shares
150,615.00
150,615.00
150,615.00
150,614.62
150,614.62
Total Operating Income as Reported
192,576.00
192,576.00
192,383.00
164,375.00
127,657.00
Total Expenses
767,135.00
767,135.00
727,679.00
651,807.00
533,419.00
Net Income from Continuing & Discontinued Operation
149,685.00
149,685.00
151,842.00
125,379.00
100,753.00
Normalized Income
150,360.66
150,360.66
150,172.46
133,809.98
100,414.09
Interest Income
5,959.00
5,959.00
5,227.00
2,140.00
557.00
Interest Expense
13,487.00
13,487.00
7,254.00
2,686.00
1,674.00
Net Interest Income
-7,940.00
-7,940.00
-2,303.00
-6,847.00
-4,632.00
EBIT
197,458.00
197,458.00
193,056.00
160,974.00
124,958.00
EBITDA
262,436.00
262,436.00
244,904.00
216,331.00
161,402.00
Reconciled Cost of Revenue
634,481.00
634,481.00
582,113.00
524,717.00
422,499.00
Reconciled Depreciation
64,978.00
64,978.00
51,848.00
55,357.00
36,444.00
Net Income from Continuing Operation Net Minority Interest
149,685.00
149,685.00
151,842.00
125,379.00
100,753.00
Total Unusual Items Excluding Goodwill
-827.00
-827.00
2,041.00
-10,605.00
413.00
Total Unusual Items
-827.00
-827.00
2,041.00
-10,605.00
413.00
Normalized EBITDA
263,263.00
263,263.00
242,863.00
226,936.00
160,989.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-151.34
-151.34
371.46
-2,174.03
74.09
9/30/2021 - 9/28/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BIG1.DE Bio-Gate AG
0.7400
0.00%
 
BOX.DE Becton, Dickinson and Company
228.00
-1.38%
 
IUI1.DE Intuitive Surgical, Inc.
527.10
+1.05%
 
COLOBc.XC
 
SSSGY Sartorius Aktiengesellschaft
36.53
0.00%
 
56S1.DE Sartorius Stedim Biotech S.A.
206.00
+3.23%
 
FIEd.XC
 
SKANz.XC
 
ANSLY Ansell Limited
85.32
0.00%
 
SRT3.BE Sartorius AG
244.20
+4.36%